Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term open-label ART621 plus methotrexate in rheumatoid arthritis
2009-014824-40Phase 2Terminated
- Sponsor
- Arana Therapeutics
- Start
- Sep 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of placulumab in rheumatoid arthritis (RA), sponsored by Arana Therapeutics. Primary endpoint: Long-term safety and tolerability of ART621. Started Sep 2009; status: terminated.
02
Drugs
placulumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-014824-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014824-40.